|
Volumn 51, Issue 63, 1997, Pages
|
Economic evaluation of benazepril in chronic renal insufficiency
a a a a |
Author keywords
Benazepril; Chronic renal insufficiency; Economic evaluation
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BENAZEPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PLACEBO;
BENZAZEPINE DERIVATIVE;
CREATININE;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DOUBLE BLIND PROCEDURE;
HEALTH CARE COST;
HEMODIALYSIS;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ARTICLE;
BLOOD;
COST;
ECONOMICS;
MULTICENTER STUDY;
PROBABILITY;
PROSPECTIVE STUDY;
RENAL REPLACEMENT THERAPY;
STATISTICAL MODEL;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZAZEPINES;
COSTS AND COST ANALYSIS;
CREATININE;
DOUBLE-BLIND METHOD;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MARKOV CHAINS;
MODELS, ECONOMIC;
PROSPECTIVE STUDIES;
RENAL DIALYSIS;
|
EID: 0031473474
PISSN: 00986577
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (25)
|
References (9)
|